News

AstraZeneca Buy of Actavis’ Respiratory Products Complete

US Extends List of Climate-Friendly Refrigerants

Burkhard Quellenberg is new Global Director HR at Oxea

Burkhard Quellenberg (47) is Oxea's new Global Director Human Resources.

New Sanofi Chief’s “Welcome Bonus” Slammed

Actavis Hormonal IUD Wins FDA Approval

Bayer MaterialScience Buys Composites Specialist

BASF and Toda Kogyo Agree JV on Cathode Materials for Batteries

Bachem acquires American Peptide Company

RWE Poised to Sell DEA Arm to Russian Tycoon

Baumann Says He’ll Fight to Keep Bayer Independent

US House Restricts EPA's Scientific Advisory Board

Novartis Gets Green Light to Buy GSK Cancer Drugs

Bayer's Carve-Out of MaterialScience on Track for 2016

US Court Orders J&J to pay $136 Million in Risperdal Case

ECHA publishes REACh Evaluation Report 2014

Chevron Quits Shale Gas Market in Romania, too

Chemtura Reports Fourth Quarter 2014 Financial Results

Funds Advised by Apax Partners to Acquire Azelis From 3i

German Chemical Industry Sees Weak Close to 2014

Richard Pott Picked to Chair Bayer MaterialScience Supervisory Board

Activist hedge funds' Assets Swell Six-fold in ten Years

Solvay to Build New Plant for PEEK Resins in US

Karyn Ovelmen to Step Down as LyondellBasell CFO

China Mulling Mergers Among State Oil Companies?

Sanofi and Lead Pharma Seal Autoimmune R&D Pact

FDA Eases Path to Genetic Disease Screening

Yara and BASF Building Ammonia Plant in Texas

Avella to Distribute Bayer’s Nexavar and Stivarga in US

Merck & Co Analyst Pleads Guilty to Insider Trading

Sabic CEO Al Mady Leaving for Government Job

Chinese Market for Colorectal Cancer Drugs Exploding

BASF and Petronas to Build Malaysian 2-EHAcid Plant

Emerald Kalama Appoints Tsai as Director, Product Commercialization

Olivier Brandicourt to leave Bayer and become CEO of Sanofi

Lanxess to Maintain Dividend at 50 Cents

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Interview

Navigating Uncertainty and Driving Innovation

Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing